Gene Therapy Market is projected to grow at an annualized rate of 45%, till 2030

by: admin

2 weeks ago

No Comments

Encouraging clinical results across various metabolic, hematological and ophthalmic disorders have inspired research groups across the world to focus their efforts on the development of novel gene editing therapies. In fact, the gene therapy pipeline has evolved significantly over the past few years, with three products being approved in 2019 alone; namely Beperminogene perplasmid (AnGes), ZOLGENSMA® (AveXis) and ZYNTEGLO™ (bluebird bio). Further, there are multiple pipeline candidates in mid to late-stage (phase II and above) trials that are anticipated to enter the market over the next 5-10 years.

The USD 11.6 billion (by 2030) financial opportunity within the Gene Therapy Market has been analyzed across the following segments:

Key therapeutic areas

Autoimmune disorders
Cardiovascular diseases
Genetic disorders
Hematological disorders
Metabolic disorders
Ophthalmic disorders
Oncological disorders
Others

Type of vector

Adeno associated virus
Adenovirus
Herpes simplex virus type 1
Lentivirus
Plasmid DNA
Retrovirus
Vaccinia Virus

Type of therapy

Ex vivo
In vivo

Type of gene modification

Gene augmentation
Immunotherapy
Oncolytic therapy
Others

Route of administration

Intraarticular
Intracerebellar
Intramuscular
Intradermal
Intravenous
Intravitreal
Intravesical
Subretinal
Others

Key geographical regions

North America
Europe
Asia-Pacific

Get Detailed Sample Report: https://www.rootsanalysis.com/reports/268/request-sample.html

The Gene Therapy Market (3rd Edition), 2019-2030 report features the following companies, which we identified to be key players in this domain:

Advantagene
Advaxis
BioMarin
bluebird bio
FKD Therapies
Freeline Therapeutics
GenSight Biologics
Gradalis
Inovio Pharmaceuticals
Marsala Biotech
Orchard Therapeutics
Pfizer
Sarepta Therapeutics
Spark Therapeutics
Tocagen
Transgene
uniQure Biopharma
VBL Therapeutics
ViroMed

Table of Contents

Preface
Executive Summary
Introduction
Gene Delivery Vectors
Regulatory Landscape and Reimbursement Scenario
Competitive Landscape
Marketed Gene Therapies
Key Commercialization Strategies
Late Stage (Phase II/III and Above) Gene Therapies
Emerging Technologies
Promising Therapeutics Areas
Patent Analysis
Mergers and Acquisitions
Funding and Investment Analysis
Cost Price Analysis
Big Pharma Players: Analysis of Gene Therapy Related Initiatives
Market Forecast and Opportunity Analysis
Vector Manufacturing
Case Study: Gene Therapy Supply Chain
Conclusion
Interview Transcripts
Appendix 1: Tabulated Data
Appendix 2: List of Companies and Organizations

Request for Customization:

https://www.rootsanalysis.com/reports/268/request-customization.html

About Roots Analysis

Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at info@rootsanalysis.com

Contact Information

Roots Analysis Private Limited

Gaurav Chaudhary

+1 (415) 800 3415

Gaurav.Chaudhary@rootsanalysis.com

Gene Therapy Market